Brian D Radbill, MD

Clinical Focus

• Chronic Renal Failure
• Dialysis
• Glomerulonephritis
• Hematuria
• High Blood Pressure
• Hypertension (High Blood Pressure)
• Kidney Biopsy
• Kidney Failure
• Kidney Stones

Show More

• Chronic Renal Failure
• Dialysis
• Glomerulonephritis
• Hematuria
• High Blood Pressure
• Hypertension (High Blood Pressure)
• Kidney Biopsy
• Kidney Failure
• Kidney Stones
• Nephrotic Syndrome
• Renovascular Hypertension

Research

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:10

Article:10

Review Article:2

Comment/Debate:1

Chapter:1

Recent Artifacts

• The Impact of Bedside Interdisciplinary Rounds on Length of Stay and Complications
• Data-driven identification of risk factors of patient satisfaction at a large urban academic medical center
• Effect of cholecalciferol supplementation on inflammation and cellular alloimmunity in hemodialysis patients: Data from a randomized controlled pilot trial
• The surgical management of renal hyperparathyroidism
• Diabetic kidney disease in the elderly: Diagnosis, treatment goals, and management
• Clinical and molecular epidemiology of methicillin-resistant staphylococcus aureus among patients in an ambulatory hemodialysis center
• Diagnosis, treatment goals, and Management of diabetic kidney disease in the elderly
• Erratum: 25-OH-vitamin D deficiency and cellular alloimmunity as measured by panel of reactive T cell testing in dialysis patients (American Journal of Transplantation (2010) 10 (2287-2295) DOI: 10.1111/j.1600-6143.2010.03264.x)
• Loss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen i expression
• Retained Catheter Fragment from a Fractured Tunneled Catheter-A Rare and Potentially Lethal Complication

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Radbill during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.